Effects of Oral Probiotic Product on Vaginal Microbial Community and Parameters of Vaginal Health

Vaginal Health Clinical Trial

Official title:
An Open-label, Pilot Study to Assess the Effects of an Oral Probiotic Product on the Vaginal Microbial Community and on Parameters of Vaginal Health

Status Completed

Clinical Trial Summary

The purpose of the study is to assess the efficacy and safety of an oral probiotic product on the vaginal microbiome and on parameters of vaginal health. Eligible subjects will utilize the investigational product as directed for a period of 28 days. The vaginal microbial community and parameters of vaginal health will be measured at baseline and after 14 and 28 days of supplementation. A follow-up post-supplementation visit will be conducted on Day 42.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Vaginal Health

Clinical Trial Details

NCT number	NCT03543982
Study type	Interventional
Source	UAS Labs LLC
Contact
Status	Completed
Phase	N/A
Start date	May 23, 2018
Completion date	March 18, 2021

View Details

See also
Status	Clinical Trial	Phase
Active, not recruiting	`NCT06124313` - A Single Group Study to Evaluate the Effects of a Vaginal Probiotic on Vaginal and Digestive Health	N/A
Completed	`NCT03574844` - Effect of Oral Probiotic Yeast on the Composition of the Vaginal Microbiota in Healthy Women	N/A
Completed	`NCT00908570` - Topical Estriol for Vaginal Health	Phase 1
Active, not recruiting	`NCT05330091` - Garden of Life Once Daily Women's Probiotic: Vaginal pH and Quality of Life Study